» Articles » PMID: 23017154

Effective Pharmacological Treatment of Painful Diabetic Neuropathy by Nurse Practitioners: Results of an Algorithm-based Experience

Overview
Journal Pain Med
Date 2012 Sep 29
PMID 23017154
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective:   To improve the care of patients with painful diabetic polyneuropathy (PDP) by a specialized outpatient clinic for individuals referred by general practitioners and to determine the effects on pain, quality of life, and patient satisfaction.

Material And Methods:   One hundred twenty-one patients were prospectively enrolled. At baseline and after 12 months at end of treatment, patients filled in a set of validated questionnaires on severity and interference of pain, quality of life, anxiety and depression, and patient satisfaction with the service offered.

Setting:   The outpatient clinic is part of a regional chronic care management program, which includes both hospital-based endocrinologists and general practitioners.

Results:   Twenty-eight patients (27%) did not need any further treatment after one visit to the outpatient clinic. As initial drug, pregabalin was the most commonly prescribed drug (65%); amitriptyline was prescribed in only 30% due to its contraindications. Improvements were found in all pain scores (P < 0.05). Pain interference was improved in sleep (P < 0.01), general activity, and mood (P < 0.05). More than half of the patients (65%) were satisfied with the treatment and wished no further medication changes; 52% had a treatment success defined as pain relief ≥ 30%. Medication was stopped due to inefficacy in 9% of patients and changed due to adverse effects in 20% of the patients.

Conclusions:   A specialized outpatient clinic for patients with PDP is an effective health care service. Using diagnostic instruments and a defined treatment algorithm, significant pain reduction was achieved in the majority of patients in a relative short period of time.

Citing Articles

Patient satisfaction and patient accessibility in a small fiber neuropathy diagnostic service in the Netherlands: A single-center, prospective, survey-based cohort study.

Geerts M, Hoeijmakers J, Essers B, Merkies I, Faber C, Goossens M PLoS One. 2024; 19(4):e0298881.

PMID: 38626240 PMC: 11020963. DOI: 10.1371/journal.pone.0298881.


Effectiveness of Exposure in Vivo for Patients with Painful Diabetic Neuropathy: a Pilot Study of Effects on Physical Activity and Quality of Life.

van Laake-Geelen C, Smeets R, Goossens M, Verbunt J J Rehabil Med Clin Commun. 2021; 4:1000046.

PMID: 33884148 PMC: 8054751. DOI: 10.2340/20030711-1000046.


Biopsychosocial Rehabilitation Treatment "Exposure " for Patients with Painful Diabetic Neuropathy: Development of a Treatment Protocol.

van Laake-Geelen C, Smeets R, van Meulenbroek T, den Hollander M, Goossens M, Verbunt J J Rehabil Med Clin Commun. 2021; 2:1000015.

PMID: 33884116 PMC: 8008735. DOI: 10.2340/20030711-1000015.


Pathways in the diagnosis and management of diabetic polyneuropathy.

Kaku M, Vinik A, Simpson D Curr Diab Rep. 2015; 15(6):609.

PMID: 25899758 PMC: 4440893. DOI: 10.1007/s11892-015-0609-2.